Terray’s Jacob Berlin on The AI-Powered Future of Medicine
Release Date: 01/08/2025
Founded & Funded
In the latest episode of Founded & Funded, Madrona Partner Vivek Ramaswami sits down with Harley Sugarman, founder and CEO of Anagram, to unpack how one pivot, a flood of cold outreach, and relentless focus on behavior change transformed a niche tool into an enterprise platform serving companies like Disney and Pfizer. From landing enterprise logos off of nothing but wireframes, to outmaneuvering the 800-lb gorilla in a legacy industry — Harley's tactics are a masterclass for any founder trying to stand out in a crowded market. Transcript:...
info_outlineFounded & Funded
What happens when a scientist becomes a VC? We sat down with Madrona’s Joe Horsman to find out. In this episode, Joe shares his journey from late nights in the lab to helping biotech founders bring life-changing science to market. You’ll hear: Why Seattle’s biotech + AI ecosystem is heating up What founders need beyond funding to commercialize world-changing science. Why weekend adventures fuel Monday creativity
info_outlineFounded & Funded
In this Founded & Funded episode, Madrona Managing Director Soma Somasegar sits down with Charles Lamanna, Corporate Vice President at Microsoft, to unpack his journey from startup founder to corporate leader. They dive into what it takes to build a successful AI-transformed organization, how the nature of business applications is evolving, and why AI agents will fundamentally reshape teams, tools, and workflows. From "customer obsession" to "extreme ownership," Charles delivers insight after insight for startup founders and enterprise leaders navigating the age of AI. They dive into: Why...
info_outlineFounded & Funded
Entrepreneurs often ask: When do I know it’s time to scale? Or, how do I lead when I wasn’t the original founder? In this week’s Founded & Funded, Madrona Partner Chris Picardo sits down with Eleanor Lightbody, CEO of Luminance, who shares how she took a promising AI product and built a company culture, go-to-market motion, and product strategy that’s scaled 6x in just two years. Eleanor’s candor and tactical insights on hiring, selling, and navigating founder dynamics make this a must-listen. Transcript: Chapters: (00:00) Introduction (01:29) Eleanor's Career Journey (03:22)...
info_outlineFounded & Funded
Most startups bolt AI onto old products. @ravennahq reimagined the entire workflow. When we first met Kevin Coleman and Taylor Halliday, it was clear they weren’t just chasing the hype cycle. They were pairing AI-native architecture with deep founder-market fit, and rebuilding how internal ops work — from first principles. Their new company, Ravenna, is going after a $160B+ market dominated by legacy players. But instead of being intimidated by incumbents, they got focused, making some smart moves that more early-stage teams should consider: 1) Speak with 30+...
info_outlineFounded & Funded
In this episode of Founded & Funded, Madrona Managing Director Soma Somasegar sits down with Anoop Gupta, co-founder and CEO of @SeekOut — an AI-first company transforming how organizations discover, hire, and manage talent. They explore: 1) SeekOut’s evolution from LLM-powered workflows to the launch of SeekOut Spot, their agentic AI solution that delivers hires in as little as 3 days. 2) Why "service as software" is the future of recruiting. 3) How founders and talent leaders can reimagine hiring in the age of AI agents. 4) Lessons from building an AI-native...
info_outlineFounded & Funded
This bonus episode of Founded & Funded is a follow-up to Madrona Partner Jon Turow's conversation with Douwe Kiela, CEO of Contextual AI and co-inventor of RAG. In this quick chat, they dive into: 1) Why storytelling—not just GTM—needs to be vertical2) How to build a platform by showing what’s possible3) The tension between “doing one thing well” vs. building the whole stack 4) Multimodal content moderation at Meta & what it taught Douwe This 10-minute post-show chat is a must-listen for founders thinking deeply about where to plant your flag — and when to break the rules....
info_outlineFounded & Funded
Microsoft Chairman & CEO Satya Nadella sat down with Madrona Managing Director Soma Somasegar at Madrona’s 2025 Annual Meeting to discuss the key inflection points in his leadership journey, Microsoft’s AI strategy, and the massive economic impact AI will have on the world. From redefining company culture to betting big on AI and OpenAI,Satya shares deep insights into Microsoft’s transformation — and what’s next. Watch now for leadership lessons, AI predictions, and the future of innovation! Transcript:...
info_outlineFounded & Funded
What does it take to invent a foundational AI paradigm — and then build a company to bring it to the enterprise? In this episode of Founded & Funded, Madrona Partner Jon Turow sits down with Douwe Kiela, co-founder and CEO of Contextual AI and the co-inventor of RAG (Retrieval Augmented Generation). They dive into the origins of RAG, its misunderstood role in the enterprise, and how Contextual is redefining what production-grade AI systems can do. Douwe shares what most companies get wrong about RAG, why chunking shouldn't matter, how to think about hallucinations, and what founders...
info_outlineFounded & Funded
The security industry has a math problem: 12 million job postings, only 7 million qualified professionals. The solution? AI. Edward Wu spent nearly a decade at ExtraHop, pioneering AI-driven security detection. But instead of just alerting security teams about potential threats, he saw a bigger opportunity — what if AI could act as an actual security analyst? That question led to Dropzone, a company that’s not just throwing AI at security but strategically using it to solve one of the most overwhelming problems in the industry — alert fatigue. In this episode of Founded & Funded,...
info_outlineTerray Therapeutics CEO Jacob Berlin returns to Founded & Funded after three years to share how the company has scaled from an ambitious startup to an industry leader in AI-driven biotech. Learn how Terray's proprietary hardware combined with the world's largest chemistry data set is powering new discoveries in small molecule drug development.
Jacob also discusses how the company’s $120M Series B fundraise will prepare their internal programs for clinical trials and further enhance their AI platform. He shares insights on where he sees the future of AI and drug design and dives into how founders can balance internal innovation and high-profile partnerships.
Don’t miss this deep dive into the intersection of AI, biotech, and innovation!
Transcript: https://www.madrona.com/terray-jacob-berlin-on-the-ai-powered-future-of-medicine
Chapters:
(00:00) Introduction 00:39 The Evolution of Terray Therapeutics
(02:08) Understanding Small Molecule Therapies
(04:12) The Journey of Data and AI
(07:58) Series B Fundraise and Future Plans
(11:20) Biotech Platform vs. Product Debate
(14:20) Building a Long-Term Vision
(16:39) Deep Dive into Terray’s AI and Science
(36:05) The Importance of Partnerships
(39:20) High-Performance Culture at Terray